New Zealand markets open in 1 hour 40 minutes

Spyre Therapeutics, Inc. (SYRE)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
37.38-1.91 (-4.86%)
At close: 04:00PM EDT
37.38 0.00 (0.00%)
After hours: 04:01PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.58B
Enterprise value 1.43B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)861.33
Price/book (mrq)N/A
Enterprise value/revenue 2.08k
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3947.73%
S&P500 52-week change 326.16%
52-week high 347.97
52-week low 32.65
50-day moving average 337.12
200-day moving average 321.70

Share statistics

Avg vol (3-month) 3497.4k
Avg vol (10-day) 3318.74k
Shares outstanding 540.28M
Implied shares outstanding 640.28M
Float 826.56M
% held by insiders 14.96%
% held by institutions 189.09%
Shares short (30 Apr 2024) 44.38M
Short ratio (30 Apr 2024) 413.53
Short % of float (30 Apr 2024) 413.92%
Short % of shares outstanding (30 Apr 2024) 410.88%
Shares short (prior month 28 Mar 2024) 43.01M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:25
Last split date 308 Sept 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-21,305.23%

Management effectiveness

Return on assets (ttm)-33.93%
Return on equity (ttm)-391.81%

Income statement

Revenue (ttm)688k
Revenue per share (ttm)0.05
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -146.03M
Net income avi to common (ttm)-364.22M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)484.64M
Total cash per share (mrq)12.03
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)11.38
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)-110.82M
Levered free cash flow (ttm)-16.47M